Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment
Saved in:
Main Authors: | Tianru Jin (Author), Mingyao Liu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
by: Zeqi Zhou, et al.
Published: (2021) -
Insomnia drug therapy in COVID-19 patients; a Letter to Editor
by: Ali Rismanbaf
Published: (2020) -
Letter to the editor: The effect of hydroxychloroquine on COVID-19
by: Canan Demir, et al.
Published: (2022) -
Hope and fear; Paxlovid for COVID-19 treatment: A Letter to the Editor
by: Alireza Pouramini, et al.
Published: (2022) -
Letter to the Editor: The Role of D-Dimers in the Initial Evaluation of COVID-19 [Letter]
by: Patel S
Published: (2022)